Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | NAPB | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | AURKA | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
mRNA | ATL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | ZNF516 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | SLC35E2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | FXYD6 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | DTNA | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |